Recent Finacing
Recent Raise
NorthSea Therapeutics develops structurally engineered fatty acids (SEFAs), advancing oral lead icosabutate for NASH alongside SEFA-1024 and SEFA-6179 in clinical development, and licenses its SEFA library from Pronova.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
